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Summary 
Pentosan polysulfate (PPS) has been shown to improve symptoms of patients with osteoarthritis (OA) when studied 
under double-blinded conditions. Laboratory studies indicated that this drug exhibits multiple actions, including the 
preservation of articular cartilage (AC) proteoglycans in animal models of OA and the stimulation of hyaluronan 
synthesis by synovial fibroblasts in vitro and in vivo. As PPS is strongly anionic and has a molecular weight of ~ 5700 Da 
its ability to enter connective tissues rich in proteoglycans and interact with the resident cells has been questioned. 
In the present studies, experiments were undertaken to isolate and characterize proteins in human AC which have the 
potential to bind PPS. Thrombospondin was identified in 4.0 M GuHC1 extracts of human AC as a PPS-binding protein. 
Furthermore, synovial fibroblasts derived from OA joints were shown to secrete thrombospondin a d also bind PPS. 
Using bovine erythrocytes conjugated with PPS a rosetting of the synovial fibroblast could be demonstrated. The level 
of rosetting was not affected by pre-incubating cultures with thrombospondin antibody suggesting that PPS was 
interacting directly with the cells. Kinetic studies of 3H-PPS uptake by Synovial fibroblasts howed saturation of binding 
sites within 30 rain when cells were maintained at 4°C but preservation of drug uptake for up to 120 min when cells 
were cultured at 37°C. These data, together with the finding that cells labeled with drug at 37°C showed higher 
incorporation, than at 4°C after trypsin digestion suggests that PPS first binds to the cell membrane then at 37°C is 
internalized, possibly by pinocytosis. 
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Introduction 
ALTHOUGH PENTOSAN POLYSULFATE (PPS) has  been 
used for a number  of years for the t reatment  of 
thrombot ic  and hyper l ip idemic indicat ions [1], it 
has only recent ly  been shown to be effective in 
improving the symptoms of pat ients with osteoar- 
thr it is  (OA) [2]. This drug, when given parentera l ly  
as the sodium salt or oral ly as the calc ium 
derivative, was also effective in modulat ing cy- 
tokine activit ies and preserving cart i lage proteo- 
glycans in animal models [3-7]. Fur thermore,  our  
previous studies had shown that PPS st imulated 
in vitro hya luronan (HA) synthesis by synovial  
f ibroblasts from rheumato id  and osteoarthr i t ic  
jo ints [8], as well as raised the molecular  weight of 
HA in fluids of inf lamed rat subcutaneous 
Submitted 18 April 1995; accepted 14 August 1995. 
Nongporn Hutadilok was a recipient of a post-graduate 
studentship from the University of Sydney. 
Address correspondence to: Associate Professor Peter Ghosh, 
Raymond Purves Bone and Joint Research Laboratories, Royal 
North Shore Hospital of Sydney, St Leonards, NSW, 2065, 
Australia. 
air-pouches [9]. This latter  effect of PPS was 
conf irmed in a human study which showed that  
after  two weekly int ra-art icu lar  inject ions of 50 mg 
of the drug into rheumato id  joints, the molecu lar  
weight of synovial  fluid HA and thus viscosity was 
increased. After seven injections, HA molecu lar  
weight was raised by 69% from 3.99x106 to 
6.75 × 106 Da, whereas in a matched sal ine- injected 
group no signif icant changes in viscosity were 
observed [10]. 
It would seem from the aforement ioned studies 
that  PPS, despite its high anionic charge and 
molecular  weight (~ 5700 Da), is not  excluded from 
enter ing the extracel lu lar  space of connect ive 
tissues and interact ing with res ident cells. Radio- 
labeled PPS, when administered subcutaneous ly  to
rats, is present  in ar t icu lar  cart i lage and disc 
t issues 48 h later [11]. Moreover, it has also been 
shown using a s t ructura l ly  re lated polysaccha- 
ride, glycosaminoglycan polysulfate ster, that  such 
anionic molecules may actual ly  accumulate in 
cart i lage and f ibrocart i lage after in t ramuscu lar  
administrat ion [12]. Radiolabeled PPS, when 
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injected intra-articularly into rabbit knee joints, 
could be extracted from articular cartilage and 
fibrocartilage of the menisci [13]. The drug 
co-extracted with proteoglycans and non-collage- 
nous components but co-fractionated with the high 
molecular weight proteins (>200 000 Da) on gel 
exclusion chromatography [13], suggesting inter- 
action with one or more of these components. 
Connective tissues contain numerous non- 
collagenous proteins [14], however, there are 
relatively few with molecular weights within the 
range identified for the PPS-binding proteins. One 
high molecular weight matrix proteins is throm- 
bospondin, an adhesive glycoprotein which has 
been shown to be present in ovine articular 
cartilage and menisci [15, 16]. Thrombospondin is
also a secretory product of platelets [17], endo- 
thelial cells [18], smooth muscle cells [19] and 
fibroblasts [20]. Apart from binding to specific sites 
on the surface of these cells, it also forms 
macromolecular complexes with other molecules, 
including heparin [17] which, like PPS, is a 
polysulfated polysaccharide. These interactions of 
thrombospondin have been implicated in a variety 
of cellular activities including division, migration 
and the biosynthesis of matrix components [21]. 
On the basis of the above observations, we 
formulated the hypothesis that thrombospondin 
could be a binding protein for PPS and that the 
formation of PPS-thrombospondin complexes 
within the extracellular matrix might augment he 
interaction of this drug with fibroblasts and other 
mesenchymal cells. 
The present study was undertaken to test this 
hypothesis using extracts of human articular 
cartilage and cultures of synovial fibroblasts 
derived from osteoarthritic joints. 
Mater ia l s  and  Methods  
Institute of Medical Research, Royal North Shore 
Hospital, Australia. 
ARTICULAR CARTILAGE EXTRACTION 
Articular cartilage was dissected from femoral 
heads, within a few hours of surgery, washed twice 
with ice cold phosphate buffered saline (PBS) and 
finely diced. The fragments were then extracted 
with 4.0 M Guanidine HC1 (GuHC1) (Sigma Chemi- 
cal Co., St. Louis, MO, U.S.A.) buffered with 50 mM 
Tris-HC1 (pH 7.4), containing the proteinase inhibi- 
tors, as described previously [3, 13]. Briefly, 1 g of 
the tissue was mixed with 10 ml of:the extraction 
buffer at 4°C for 24 h, the extracted residue was 
removed by filtration through Miracloth '~ (Cal- 
biochem Corp., San Diego, CA, U.S.A.) and the 
filtrate used for subsequent experiments. 
GEL F ILTRAT ION CHROMATOGRAPHY 
In these experiments, I ml of the 4.0 M GuHC1 
extracts were mixed with ~H-PPS (specific activity 
10 tl Ci/mg, Benechemie GmbH, Munich, Germany) 
(20 pg) prior to application to a gel filtration system 
consisting of a Sephadex G25 desalting column 
(1.6x20 cm) placed in series with a Sepharose 
CL-2B column (1.6 x 95 cm) (Pharmacia-Kabi, Syd- 
ney, Australia). The columns were operated at a 
flow rate of 9.6 ml/h at 4°C using 50 mM phosphate 
buffer (pH 7.5) as eluant. The fractions collected 
(3 ml) were analyzed for sulfated glycosaminogly- 
cans by the dimethylmethylene blue (Aldrich 
Chemical Co., Castle Hill, NSW, Australia) assay 
[22], protein was determined using bicinchoninic 
acid (Pierce Chemical Co., Rockford, IL, U.S.A.) 
[23] and thrombospondin by an enzyme-linked 
immunosorbent assay (ELISA) technique, as de- 
scribed below. [3H]-PPS radioactivity was detected 
in fractions by scintillation spectroscopy. 
SOURCES OF  CELL  AND T ISSUES 
Human articular cartilage was obtained from the 
femoral heads of female patients (65-75 years old) 
undergoing joint replacement surgery for fracture 
of the neck of femur at the Royal North Shore 
Hospital. The synovial fibroblasts used in this 
study were grown from the synovial tissues which 
were collected at the time of total joint replace- 
ment for osteoarthritis by Dr M. Cross of the Mater 
Misericordiae Hospital, Crows Nest, Sydney, 
Australia. Recently outdated human platelet 
concentrates were donated by the Blood Bank Unit 
at the Royal North Shore Hospital. Bovine blood 
was provided by Dr M. A. King of the Kolling 
PREPARATION OF THROMBOSPONDIN 
Human blood platelet concentrates were pooled, 
washed and reacted with thrombin as previously 
described by Margossian [24]. After 2 min, the 
thrombin inhibitor, hirudin, was added (6 units/ml) 
(one unit will neutralize 1 NIH unit of thrombin at 
37°C). The platelet aggregates were then removed 
by an initial centrifugation at 200 g for 5 min at 4°C 
followed by a second centrifugation at 20 000 g for 
30 min at 4°C. Thrombospondin was isolated from 
the supernatant of these thrombin-activated 
platelets by employing the procedure of Mosher 
and colleagues [18]. The purity of thrombospondin 
prepared by the published methods was confirmed 
by sodium dodecyl sulphate (SDS)-electrophoresis 
(PhastSystem, Pharmacia AB, Uppsala, Sweden). 
800 
PREPARATION OF  THE PPS-AFF IN ITY  COLUMN 
Immobilization of PPS (Benechemie GmbH, 
Munich, Germany) was achieved by direct coupling 
of this compound, through its hydroxyl groups, to 
Epoxy-activated Sepharose 6B (Pharmacia AB, 
Uppsala, Sweden). In this preparation, 6ml of 
Epoxy-activated Sepharose 6B was gently mixed 
with 50 mg PPS in 25 ml of 0.1 M carbonate/bicar- 
bonate buffer pH 9.0 at 200C up to 18 h. The gel was 
then sequentially washed with 100ml each of 
distilled water, 0.1 M carbonate/bicarbonate buffer 
pH 8.5, and 0.1 M acetate buffer pH 4.0. In order to 
block the remaining free oxirane groups on the gel, 
34 ml of 1 M ethanolamine was added and the 
solution was allowed to stand for 16 h at 20°C. 
Finally the gel was washed with 40 ml of 0.15 M 
NaC1 in 10 mM phosphate buffer, pH 7.5 and stored 
in this buffer at 4°C. 
The amount of PPS attached to the gel was 
estimated from the amount found in the combined 
washings by the method of Farndale et al. [22] 
using pure PPS directly as a standard. The method 
indicated a substitution of 5 mg of PPS per ml 
wet gel. 
EL ISA OF  THROMBOSPONDIN 
Aliquots of fractions from the gel-filtration 
column (100 #1) were placed in each well of a 
96-well immunoplate (activated polyvinyl chloride 
microplate, T ITERTEK TM, Flow Laboratories, 
Zwanenburg, The Netherlands) and left at 37°C for 
I h. The plate was then washed three times with 
100 pl of 0.05% (v/v) Tween 20 in 0.15 M NaC1 in 
10 mM PBS, pH 7.3 fol lowed by the addition of 
100 pl of 1% (w/v) bovine serum albumin (BSA) in 
PBS. After incubation at 37°C for I h, the plate was 
washed as before and 100pl of 1.4pg/ml mouse 
monoclonal anti-thrombospondin (kindly provided 
by Dr Joan Dawes, The Heart  Research Institute, 
Sydney, Australia) in PBS was added. Plates were 
then incubated for l h (at 37°C, washed as 
previously described and 100 pl of 1:1000 peroxi- 
dase-conjugated rabbit anti-mouse immuno- 
globulins (Dakopatts, Glostrup, Denmark) was 
dispensed into each well. After a further incu- 
bation at 37°C for 1 h, the plate was washed and 
100 pl of the substrate solution [5 pl of 30% (w/v) 
hydrogen peroxide in 12ml 0.1M citric acid- 
phosphate buffer pH 5.0 containing four tablets 
(8 mg) of 1,2-phenylenediamine dihydrochloride 
prepared as per Dakopatts recommendation], 
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FIG. 1. A Sephadex G25/Sepharose CL-2B elution profile of 
a 4 M GuHC1 extract of human articular cartilage (100 mg) 
run in the presence of 20/lg 8H-PPS. (a) The radioactivity 
profile determined by scintillation spectrometry. (b) The 
sulfated proteoglycan distribution as determined by the 
dimethylmethylene blue assay [22]. (c) The protein profile 
determined using the BCA assay [23]. (d) Thrombo- 
spondin activity in the extract as detected by the ELISA 
assay (see text). The vertical broken line indicates the 
elution position of a purified thrombo-spondin sample 
(subunit molecular weight ~ 150 000 Da) run on the same 
column system. The V0 and Vt of the Sepharose CL-2B 
column were determined by the calf thymus DNA and 
NA285SO4, respectively. Note that coinciding peaks of 
sH-PPS radioactivity and that of thrombospondin in the 
extract. 
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TsP  
Fro. 2. High resolution of sodium dodecyl sulphate-poly- 
acrylamide gel electrophoresis ona PhastGel tm gradient 
10-15 in the PhastSystem. The right lane contains the 
protein standards specified as myosin [molecular weight 
(Mr) of 212 000], ~-macroglobulin (Mr = 170 000), fl-galac- 
tosidase (M~= 116 000), transferring (Mr = 76 000), and 
glutamic dehydrogenase (Mr = 53 000), respectively. The 
left lane shows a single band of the mercaptoethanol-re- 
duced thrombospondin purified (TSP) from human 
platelets corresponding to the subunit (Mr = 150 000). 
The gel was stained sequentially with PhastGel tm silver 
kit as instructed by the manufacturer (Pharmacia LKB 
Biotechnology AB, Uppsala, Sweden). 
was added. Plates were left in the dark at 20°C for 
at least 20min before the color reaction was 
stopped by the addition of 25 pl of 4 M H2SO4 and 
chromogen was monitored by measuring the 
dual-wavelength absorpt ion at 492 and 690nm 
using a TITERTEK t~ twinreader [Flow Labora- 
tories (Australia) Pty. Ltd., Seven Hills, NSW, 
Australia]. 
SYNOVIAL FIBROBLAST (SYNOVIOCYTE) CULTURES 
Synovial fibroblasts were prepared from synovial 
specimens removed at surgery using the procedure 
described by Smith and Ghosh [25]. Briefly, tissues 
were washed three times and diced in sterile 
Dulbecco's calcium and magnesium-free phos- 
phate-buffered saline solution (CMF-PBS). These 
diced tissues were then placed in DMEM contain- 
ing 23 mM sodium bicarbonate, 40 ~g/ml gentam- 
ic in,  and 4 mg/ml collagenase (1 g of tissue/20 ml 
medium) for 3-4 h at 37°C with occasional mixing. 
After the incubation, an equal volume of 0.05% 
(w/v) trypsin and 0.02% (w/v) ethylenediaminete- 
traacetic acid (EDTA) in CMF-PBS, pH 7.4 was 
added. Incubation was continued for I h under 
the same conditions as above. The suspension was 
then centrifuged for 5 min at 400g at 20°C. The 
supernatant was aspirated and the cell pellet 
washed three times in CMF-PBS and finally 
suspended in DMEM containing 23 mM sodium 
bicarbonate, 40 gg/ml gentamicin and 10% (v/v) 
heat-inactivated fetal calf serum (FCS) ( lml  
pellet/20 ml medium). About 5 ml of this suspen- 
sion was then plated in 75cm 2 culture flask 
(LUX tin, Miles Laboratories Australia Pty. Ltd., 
Epping, NSW, Australia). The flasks were left 
for 24 h at 37°C in a humidified atmosphere of 
95% (v/v) air and 5% (v/v) carbon dioxide. They 
were then rinsed vigorously twice with CMF-PBS 
and 10-15 ml of fresh medium was added. The 
synoviocytes were grown and maintained in a 
monolayer culture under the above described 
conditions with media changes every 2 to 3 days. 
Fibroblasts were collected or subcultured by 
trypsinization with 0.1% (w/v) trypsin and 0.25% 
(w/v) EDTA in CMF-PBS, pH 7.4 on reaching 
confluency. 
INDIRECT IMMUNOFLUORESCENT MICROSCOPY 
Synoviocytes were seeded into an eight-well 
tissue culture chamber slide (Lab-Tek ®, Nunc, Inc., 
Naperville, IL, U.S.A.) at a density of 40 000~0 000 
cells/0.4 ml DMEM with 10% (v/v) FCS/weI1. Upon 
reaching confluency, cells were rinsed three times 
with 0.45 ml of Hanks' balanced salt solution 
(HBSS) and fixed with 0.3 ml of 3.5% (w/v) formalin 
in PBS, pH 7.0 for 20 min at 20°C. The cells were 
then washed four times with HBSS and incubated 
with the monoclonal antibodies to thrombospondin 
(7 ttg protein/ml) in HBSS for 1 h at 20°C. After 
three washings with HBSS, the cells were stained 
with 0.3ml of FITC-conjugated anti-mouse IgG 
(1:20 in HBSS) for 1 h at 20°C. They were again 
washed three times with HBSS. The chambers and 
gasket were removed from the slide and the cells 
were coverslipped and mounted in 50% glycerol/ 
50% PBS (v/v). Fluorescence staining was then 
observed by microscopy (Nikon tm OPTIPHOT with 
'EF' episcopic fluorescence attachments, Nippon 
Kogaku K.K., Tokyo, Japan). Negative controls, in 
which the anti-thrombospondin incubation step 
was omitted, were also included in these exper- 
iments. 
COUPLING PPS TO ERYTHROCYTES 
Bovine blood was diluted with Alsever's olution 
[20.5 g/1 glucose, 4.2 g/1 NaC1, 8.0 g/1 sodium citrate 
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and 0.55 g/1 citric acid monohydrate (pH 6.1)] and 
the red cells (bRBC) were washed four times in 20 
volumes of 0.15 M NaC1 by centrifugation at 600 ×g 
for 5 rain at 20°C just before coupling to PPS via 
chromium chloride (CrC13) as described by Parish 
and Snowden [26] and Goding [27]. These cell 
preparations [in PBS, 0.1% (w/v) BSA and 0.1% 
(w/v) sodium Azide] were viable for up to 1 week 
after coupling and the attachment of PPS to the 
bRBC surface was confirmed by indirect immu- 
nofluorescence technique. Briefly, bRBCs were 
suspended at 0.5-1×106 cells/ml in ice-cold PBS 
containing 0.1% (w/v) BSA. An aliquot of this 
suspension was incubated with an equal volume of 
1:1000 mouse monoclonal anti-PBS ascites [28] 
prepared in the same buffer for I h at 4°C. After five 
washings with PBS, the cell pellet was incubated 
with FITC-conjugated antibody to mouse im- 
munoglobulin [1:20 in PBS containing 0.1% (w/v) 
BSA] for 1 h at 4°C. The fluorescence of these 
stained RBC was detected by flow cytometry 
performed on an EPICS C t~ (Coulter Electronics 
Inc., Hialeah, FL, U.S.A.). Approximately 10 000- 
50 000 cells were analyzed in each run. The cell 
f luorescence excitation was achieved by a 400 mW, 
488-nm band of a 2-Watt argon :laser and their 
emission was measured using a 530 SP filter. 
ROSETT ING ASSAY 
Single cell suspensions of human synoviocytes 
were prepared by centrifugation (500g/5 min at 
4°C) from the confluent monolayer cultures and 
washed twice in PBS and finally resuspended in 
PBS containing 0.1% (w/v) BSA at 4°C. 
The rosetting of synoviocytes with PPS-coupled 
bRBC was carried out in 96-well round-bottom 
microplates [Flow Laboratories (Australia) Pty. 
Ltd., Seven Hills, NSW, Australia]. To 25 pl/well of 
fibroblasts (1-2× 106 cells/ml) in ice-cold PBS 
containing 0.1% (w/v) BSA was added 25 pl/well of 
1% (v/v) PPS-coupled bRBC in the same medium. 
The cells were mixed by gently shaking the 
microplate and then pelleted by centrifugation at 
200 g for i rain at 4°C. The cell pellets were then 
incubated at 2-4°C for at least 30 rain before being 
gently resuspended with a short pasteur pipette. 
Each preparation was transferred to an ethanol- 
cleaned glass microscope slide and covered with a 
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FIG. 3. Affinity chromatography of purified thrombospondin o PPS-Sepharose 6B. Arrows indicate the sequences and 
molarity of NaC1 used. Protein eluted from the column was monitored at 280 nm. A small peak of inactive material 
was eluted with starting buffer (10mM phosphate containing 0.15 M NaC1, pH 7.5). However, the majority of 
thrombospondin applied bound to immobilised PPS and was eluted with the same buffer containing high salt 
concentration (1 M NaC1). 
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HEPES, pH 7.4 in the presence of 10% (v/v) FCS at 
37°C or 4°C. Following incubation, the medium was 
removed and the monolayers washed three times 
with 2 ml of PBS containing 0.2 g/1 CaC12 and 
0.1 g/1 MgCl~-6H20, pH 7.4. After washing, the 
monolayer was solubilized in an aqueous olution 
of 1% (w/v) SDS (0.4 ml) and the dish rinsed with 
two additional 0.4ml portions of 1% SDS and 
0.5 ml of distilled water. These washings were then 
combined and the amount of 5H-radioactivity was 
quantified in a beta counter (TRI-CARB 1500 tin, 
Packard Instrument Co., IL, U.S.A.). 
The internalization of 3H-PPS by synoviocytes 
was investigated by harvesting confluent mono- 
layer cells (5× 105 cells) in 60-mm: dishes (C. A. 
Greiner and SShne GmbH & Co. KG, Germany) 
with 0.1% (w/v) trypsin and 0.2% (w/v) EDTA in 
CMF-PBS, pH 7.4, after 1-h incubation at 37°C or 
4°C with 1 #g/ml 3H-PPS in the same medium 
described above. The trypsinized cells were washed 
twice with 10 ml of CMF-PBS. The cells pelleted by 
centrifugation at 600g for 5min at 4°C were 
dissolved in 1 ml of NCS ~' tissue solubilizer 
(Amersham/Searle Corp., IL, U.S.A.) and then 
3H-radioactivity determined. 
o 
Resu l ts  
BL AL AU 
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FIG. 4. Representative flow-cytometric histograms show- 
ing (a) PPS-coupled bRBC incubated with anti-PPS and 
FITC-conjugated anti-mouse Ig, (b) control sample of 
uncoupled bRBC incubated under the same conditions 
as (a), and (c) PPS- coupled bRBC incubated with 
FITC-conjugated antibody alone. Cells were prepared 
and analyzed for fluorescence asdetailed in the text. The 
relative cell number is shown on the vertical axis and 
relative green fluorescence intensity (LGFL) is indicated 
on the horizontal axis. 
coverslip and the rosette formation observed by 
microscopy. 
BINDING OF 3H-PPS TO HUMAN SYNOVIAL FIBROBLAST 
MONOLAYERS 
The binding of PPS to synoviocyte fibroblast 
monolayers was investigated using confluent mono- 
layers of cells (3 x 105 cells) grown in 35-mm dishes 
(C. A. Greiner und SShne GmbH & Co KG, 
Germany). These cells were incubated with 1 #g/ml 
3H-PPS in 2ml of DMEM containing 20mM 
THE IN VITRO B INDING OF PENTOSAN POLYSULFATE 
(PPS)  TO ARTICULAR CARTILAGE MATRIX PROTEINS 
Superose 12 chromatography of 3H-PPS showed a 
similar profile of radioactivity for the distribution 
of molecular fractions as the elution profile for a 
PPS standard monitored for sulphated gly- 
cosaminoglycans [22]. The elution profile of a 4.0 M 
Guanidine HCI (GuHC1) extract of human articu- 
lar cartilage mixed with excess 3H-PPS obtained 
from the Sephadex G25/Sepharose CL-2B column is 
shown in Fig. 1. With this high molecular weight 
exclusion gel, 3H-PPS by itself eluted at the total 
volume of the column (data not shown). However, 
in the presence of cartilage xtracts, a proportion 
of 3H-PPS was included in the column eluting with 
the matrix proteins of molecular weights ranging 
from --. 1.0 x 106 Da-l.0 × 105 Da) as estimated from 
their Kavs (Fig. 1). The thrombospondin prep- 
aration, when examined by SDS-PAGE under 
reducing conditions, showed a subunit molecular 
weight of ~1.5 × 105 Da, that is 4.5 × 105 Da for the 
aggregate [17] (Fig. 2). When the thrombospondin 
aggregate was applied alone to the gel column as 
a reference, it also eluted in the PPS-binding 
protein region (Fig. 1). Using the ELISA assay, the 
presence of native thrombospondin cartilage 
extracts was confirmed and was found to elute in 
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the same position as the human platelet prep- 
aration (Fig. 1). Proteoglycan aggregates eluted at 
V0 and species corresponding to subunit and 
breakdown products were included in the column, 
as detected by the dimethylmethylene blue assay 
[22] [Fig. l(b)]. 
The binding of thrombospondin to PPS was 
confirmed using the PPS affinity column. In this 
experiment, thrombospondin (500#g), when ap- 
plied directly to PPS-Sepharose 6B column (5-ml 
bed volume) in the presence of PBS, was almost 
totally retained. The bound thrombospondin was, 
however, dissociated and eluted from the column 
with 1.0 M NaC1 (Fig. 3). 
IMMUNOFLUORESCENCE STUDIES 
Incubation of synoviocytes with the human 
thrombospondin monoclonal antibody, followed by 
staining with fluorescein-conjugated antibody to 
mouse IgG produced a prominent pattern of a 
brightly stained network of extracellular fibrils 
surrounding the cells when observed by fluor- 
escence microscopy. Attempts to illustrate these 
findings using black and white photography of the 
green fluorescence were unsatisfactory and are 
therefore not presented here. No fluorescence 
staining was observed with these cultures when the 
primary antibody incubation step was omitted from 
the process. 
ROSETTING ASSAY 
Using flow cytometry and the MAb-5B10, which 
was specific for PPS [28], it was confirmed that PPS 
was coupled to bRBC (Fig. 4). The ability of this 
drug to interact with the surface of synoviocytes 
was then demonstrated bythe formation of rosettes 
with bovine erythrocytes (bRBC) to which PPS was 
coupled (Fig. 5). It was found consistently that the 
majority of the fibroblasts were almost entirely 
covered with a single layer of PPS-coupled bRBC. 
These rosettes were still maintained when synovio- 
cytes were exposed to either 7 or 14/~g/ml of the 
anti-thrombospondin antibody in PBS containing 
0.1% (w/v) BSA for 1 h at 4°C prior to incubating 
with PPS-bRBC, but were disrupted in the presence 
of PPS at concentrations ~> 100 pg/ml. 
FIG. 5. Light micrograph (magnification ×800) of the rosetting of a human synovial fibroblasts derived from an 
osteoarthritic joint with PPS-coupled bRBC. These suspended synovial cells were prepared from confluent synovial 
fibroblast culture, harvested with EDTA and tested for rosette formation with PPS-bRBC, as described in the text. 
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F~G. 6. Kinetics of the binding of PPS to human synovial 
fibroblast monolayer cultures. 3H-PPS was incubated 
with the synoviocytes at a concentration of 1 pg/ml. 
After incubation for various lengths of time, the amount 
of monolayer-associated 3H-PPS was determined, as 
described in the text. Mean values for cultures incubated 
at 37°C (O) and cultures incubated at 4°C (A) are shown 
together with the computer derived lines of 'best fit'. For 
the first 30 min the uptake of 3H-PPS at 4°C and 37°C 
were similar with slopes of 5.24 and 4.57, respectively. 
After 30 min cells at 4°C showed saturation kinetics 
(slope=0.28), while viable cells (37°C) continued to 
incorporate 3H-PPS but at a slower rate (slope = 1.86). 
BINDING OF PPS BY SYNOVIOCYTES 
The kinetics of synoviocytes-associated ~H-PPS 
binding at 4°C and 37°C, as defined as the 
amount  of radioact iv i ty  (DPM) in SDS solubil- 
ized cell fractions, is shown in Fig. 6. The init ial  
uptake of 3H-PPS by cells incubated at 4°C was 
sl ightly h igher (s lope=5.24) but not stat ist ical ly 
different from those incubated at 37°C 
(slope = 4.57) for the first 30 min. However, after 
30 rain, uptake of the drug by the cells main- 
tained at 4°C reached a plateau (slope=0.28), 
while the levels associated with the 37°C-main - 
tained cells cont inued to rise, albeit at a slower 
rate (slope 1.86) than in the first 30 min (Fig. 6). 
The amount  of 3H-PPS that  was released from the 
cells by trypsin t reatment  (trypsin was found to 
diminish the rosette format ion but preserved 
synoviocytes integr i ty)  after incubat ion at 37°C 
and 4°C was determined (Table I). After incu- 
bat ion of human OA synoviocytes with 1 #g/ml 
3H-PPS for l h at 37°C, 25% of the total  
monolayer-associated 3H-PPS was reta ined after 
trypsin t reatment.  In contrast ,  only 7% of 3H-PPS 
was reta ined after t rypsin digestion of cells 
incubated at 4°C. 
Discuss ion  
A previous study by Andrews et al. [13] had 
shown that  3H-PPS, when injected into rabbit 
knee joints, became bound to art icu lar  cart i lage 
and menisci. This aff inity of cart i lage for 3H-PPS 
was also confirmed in rat exper iments in which the 
radiolabeled rug was given subcutaneous ly  [11]. 
Gel chromatography of extracts of cart i lages of 
3H-PPS-treated animals suggested that  the drug 
could be interact ing with high molecular  weight 
non-col lagenous proteins but the ident i ty  of the 
protein(s) was not resolved. In the present study, 
gel exclusion chromatography confirmed that  
3H-PPS eluted with the high molecular  weight 
proteins extracted from human art icu lar  cart i lage 
with 4.0 M GuHC1. Furthermore,  by means of an 
ELISA it was shown that  one of these binding 
proteins was probably the glycoprotein, throm- 
bospondin. 
Thrombospondin  (also known as glycoprotein G
or thrombin-sensit ive protein) is a 450-kDa protein 
composed of three ident ical  disulfide-linked sub- 
units. It was or ig inal ly identif ied in human 
platelets and descr ibed as a secret ion product  of 
these cells in response to thrombin t reatment  
[17, 18, 21, 29-31]. In addit ion to its distr ibut ion in 
the ~ granules of rest ing platelets, this glycoprotein 
has been found in associat ion with the extracel lu- 
lar matr ix  of a var iety of human tissues [32]. Thus, 
it has been identif ied in l igaments, menisci, and the 
Table I 
Temperature dependence of the binding of sH-PPS by human synovial fibroblast monolayers 
Temperature 
37°C 4°C 
Total specific cell-associated 3H-PPS (DPM) 654 + 4 686 ± 3 
3H-PPS released by trypsin treatment (DPM) 494 + 16 637 ± 10 
Cell-associated ~H-PPS remaining after trypsin treatment (DPM) 160 ± 20 49 ± 13 
Percentage of total ~H-PPS internalized (%) 25 7 
Monolayers (5 × 10 ~ cells) of human synoviocytes were incubated with 3H-PPS (1/~g/ml) for 1 h and 
processed as described in text. The values shown are means + S.D. of duplicate determinations. 
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intervertebral discs [15], as well as being isolated 
from an extract of ovine articular cartilage [16], 
suggesting that itois synthesized by chondrocytes 
[16]. Although thrombospondin is synthesized by 
various cell types [18-21], the preparations i olated 
were indistinguishable from that obtained from 
platelets [32]. In the present study, using a specific 
monoclonal antibody raised to human platelet 
thrombospondin, the existence of this protein in 
extracts of human articular cartilage was 
confirmed. It would appear that thrombospondin s 
not only a matrix constituent of cartilage, but is 
also synthesized by cultures of human synovial 
fibroblasts derived from OA joints as demonstrated 
by the immunofluorescence staining studies. More- 
over, the results obtained also indicated that 
thrombospondin was incorporated into extracellu- 
lar matrix of these cultures in a similar fashion to 
that observed for other types of cells such as 
dermal fibroblasts [19, 20], smooth muscle cells [19] 
and endothelial cells [18, 19] maintained in culture. 
Although its functional role in the extracelluar 
matrix is still unclear, a number of investigations 
have shown that thrombospondin has effects on 
cellular activities including cell adhesion to matrix 
components, cell migration, and proliferation 
[21, 33]. 
Thrombospondin is known to bind specifically 
and with high affinity to several sulfated com- 
pounds including heparin [17] and sulfated glyco- 
lipids [34]. The interaction with sulphated 
glycolipids occurred at the heparin-binding domain 
at the amino terminal of the protein molecule and 
was strongly inhibited by the polysulfated polysac- 
charides, fucoidan and dextran sulfates [34]. It was 
therefore not surprising to find that PPS also 
bound to thrombospondin. PPS which has an 
average molecular weight of ~5700 Da [35] and 
higher sulfate content than heparin [36] would 
presumably interact with the heparin-binding 
region of thrombospondin. As the structures of 
polysaccharides that bind to thrombospondin can 
be quite variable, i t  would seem that effective 
interaction is not dependent on the nature of the 
saccharide backbone but rather ionic interaction 
between the anionic sulfate ester groups present on 
the polysaccharides and cationic centers (arginine, 
lysine, histidine) on the amino-terminal domain of 
the protein. Support for such ionic interactions 
was provided by our finding that the binding of 
thrombospondin to immobilized PPS was disrupted 
at high ionic strength (Fig. 3). 
Receptors for naturally occurring or semi-syn- 
thetic sulfated polysaccharides are known to exist 
on cells of the lymphoid lineage [26,37-39]. 
Interactions of these cells with polysulfated 
polysaccharides has been shown to influence 
lymphocyte trafficking, leukocyte rolling and 
adhesion and cell-cell interactions [26, 37-39]. In 
the present study by using a sensitive and 
convenient rosetting assay, the intercellular at- 
tachment between single human synovial fibro- 
blasts and bRBC coated with PPS was clearly 
demonstrated (Fig. 4). These data provide strong 
evidence for the presence of sulfated polysaccha- 
ride receptors on the surface of human synovial 
fibroblasts. In the rosetting assay, the coupling of 
PPS to bRBC was mediated by chromium chloride 
which is considered to react with carboxyl residues 
of proteins in the RBC membrane [40]. However, 
rosetting was decreased for the human synovial 
fibroblasts because no pre-treatment with chro- 
mium chloride was required and the cells were 
harvested by trypsinization prior to the rosette 
assay. PPS was probably bound directly to cell 
surface protein(s) since the thrombospondin mono- 
clonal antibody could not prevent rosette for- 
mation but addition of free PPS did. It is possible, 
but not confirmed by the present study, that 
thrombospondin augmented the synoviocyte-PPS 
surface interactions. Multi-molecular complexes of 
this type have been described for heparin, 
thrombospondin and histidine-rich glycoprotein 
during their interactions with the platelet mem- 
brane [21]. 
Sulfated glycosaminoglycans and heparan sulfate 
proteoglycans in particular [41-43] located on cell 
surfaces may be internalized by receptor-mediated 
pinocytosis. We prepose a similar mechanism for 
the internalization of ~H-PPS by synoviocytes. Our 
studies showed that the amount of 3H-PPS retained 
by the synoviocyte monolayers was rapidly in- 
creased during the first 30 min of incubation 
irrespective of temperature. It is likely that this 
phase represents the binding of 3H-PPS to the 
synoviocyte surface receptors which, as already 
speculated upon, could be supplemented by 
thrombospondin synthesized by these cells. After 
30 min, the uptake by the synoviocyte cultured at 
4°C was minimal presumably due to saturation of 
the surface binding sites. However, with active cells 
maint~ained at 37°C the uptake of 3H-PPS contin- 
ued. We consider that this process could corre- 
spond to internalization of 3H-PPS. The trypsin 
digestion experiments ummarized in Table I are 
consistent with this interpretation since more 
3H-PPS remained associated with the cell after 
enzyme treatment when cultures were maintained 
at 37°C than at 4°C. 
As already discussed, PPS has been shown 
clinically and in laboratory models to possess a 
profile of pharmacological ctivities which would 
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qualify it as a disease modifying ant i -osteoarthr i t ic  
dru~. The present study provides evidence that PPS 
may bind to connect ive tissues and possibly 
accumulate there by interact ion with throm- 
bos~0ndin and other, as yet unidentif ied, proteins. 
Since PPS is a potent  enzyme inhibi tor  [1] and 
modulator  of immune cell activit ies [1, 6, 7, 11] the 
binding to components of the cart i laginous matr ix  
could place this drug in a favorable posit ion to 
attenuate the degradative ffects of proteinase or 
other  mediators re leased by inf lammatory cells 
present in arthr i t ic  jo ints [1, 6, 13]. In addit ion, the 
finding that PPS bound to surface 'receptors'  of 
synoviocytes and possibly became internal ized 
suggests that  this drug can not  only modulate 
events occurr ing extracel lu lar ly  but also may act 
on intracel lu lar  pathways responsible for the 
generat ion of metal loproteinases and inf lammatory 
mediators. It is noteworthy  in this regard that  PPS 
is a potent  inhib i tor  of protein kinases [44, 45]. 
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